Key result
4D flow MRI links systolic elevated velocity volume to elevated aortic peak velocity in HCM.
Why the study?
To employ 4D flow MRI to investigate associations between hemodynamic parameters with systolic anterior motion, mitral regurgitation, stroke volume, and cardiac mass in patients with HCM.
Does 4D flow MRI identify altered left ventricular blood flow dynamics in patients with hypertrophic cardiomyopathy compared to healthy controls?
Cross-Sectional (n=24)
Does 4D flow MRI identify altered left ventricular blood flow dynamics in patients with hypertrophic cardiomyopathy compared to healthy controls?
p-value: p=<.001
4D flow MRI can quantify elevated velocity volumes in the left ventricle of HCM patients, which correlate significantly with clinical manifestations like systolic anterior motion, mitral regurgitation, and increased cardiac mass.
4D flow MRI-derived elevated velocity volume correlates with aortic velocity in HCM; this case-control association leaves open its clinical utility.
Purpose To employ four-dimensional (4D) flow MRI to investigate associations between hemodynamic parameters with systolic anterior motion (SAM), mitral regurgitation (MR), stroke volume, and cardiac mass in patients with hypertrophic cardiomyopathy (HCM). Materials and Methods A total of 13 patients with HCM (51 years ± 16 [standard deviation]; 10 men) and 11 age-matched healthy control subjects (54 years ± 15; eight men) underwent cardiac 4D flow MRI data analysis including calculation of peak systolic and diastolic control-averaged left ventricular (LV) velocity maps to quantify volumes of elevated velocity (EVV) in the left ventricle. Standard-of-care cine imaging was performed in short-axis, LV outflow tract (LVOT), and two-, three-, and four-chamber views on which the presence of SAM, presence of MR, total stroke volume, and cardiac mass were assessed. Results Systolic EVV in patients with HCM was 7 mL ± 5, which was significantly associated with elevated aortic peak velocity (R = 0.87; P < .001), decreased LVOT diameter (R = 0.68; P = .01), and increased cardiac mass (R = 0.62; P = .02). In addition, EVV differed significantly between patients with and those without SAM (10 mL ± 4.7 vs 3 mL ± 2.3; P = .03) and those with and those without MR (9.9 mL ± 4.8 vs 4.0 mL ± 3.2; P < .05). In the atrial systolic phase, peak diastolic velocity in the LV correlated with septal thickness (R = 0.66; P = .01). Conclusion Quantification and visualization of EVV in the LV is feasible and may provide further insight into the clinical manifestations of altered hemodynamics in HCM.
No takes yet. Share an insight, caveat, or question.
Pruijssen et al. (2020) conducted a cross-sectional in Hypertrophic cardiomyopathy (HCM) (n=24). 4D flow MRI vs. Healthy controls was evaluated on Association of systolic elevated velocity volume (EVV) with aortic peak velocity (p=<.001). Four-dimensional flow MRI revealed that systolic elevated velocity volume in HCM patients was significantly associated with elevated aortic peak velocity (R=0.87; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: